JERUSALEM, May 09, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key ...

This letter was shared with the editor, and sent to officials at the state Department of Conservation and Recreation (DCR). We are writing to ask that you initiate a pause on the logging project ...

EMED Technologies Director of Clinical Affairs Alex Nikanorov shares the company’s approach to deciding which clinical ...